Results 21 to 30 of about 3,948 (161)
Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects [PDF]
Systemic Lupus Erythematosus is a chronic inflammatory disease with multifactorial etiology. Although clinical manifestations are varied, the skin is an important target-organ, which contributes to the inclusion of skin lesions in 4 out of the 17 new ...
Jucelio Pereira Moura Filho +6 more
doaj +1 more source
Objective To assess the efficacy of anifrolumab, a type-1 interferon receptor subunit-1 monoclonal antibody, in treating refractory cutaneous lupus erythematosus (CLE) and lupus non-specific mucocutaneous manifestations in patients with systemic lupus ...
Jun Kang, Aaron Bao
doaj +1 more source
Ocular discoid lupus erythematosus: More than what meets the eye
Lupus erythematosus is a spectrum that includes auto-immune disorders such as systemic lupus erythematosus (SLE), subacute cutaneous lupus erythematosus (SCLE), and chronic cutaneous lupus erythematosus (CCLE).
Sumiti Pareek +3 more
doaj +1 more source
Objective Lupus erythematosus (LE) is a complicated disease with highly heterogeneous clinical manifestations. Previous studies have rarely included all subgroups of patients with lupus and have overlooked the importance of the cutaneous manifestations ...
Qing Zhang +19 more
doaj +1 more source
Cutaneous lupus erythematosus (CLE) is a chronic inflammatory skin disease characterized by a diverse cadre of clinical presentations. CLE commonly occurs in patients with systemic lupus erythematosus (SLE), and CLE can also develop in the absence of ...
Lisa Abernathy-Close +18 more
doaj +1 more source
Systemic lupus erythematosus with subacute cutaneous manifestation – acute on chronic.
Systemic Lupus Erythematosus (SLE) presents as a continuum, with some patients demonstrating only cutaneous manifestations, such as Chronic Cutaneous Lupus Erythematosus (CCLE) or other more severe organ manifestations as in SLE.
Juliana Lopes, Isabel Almeida
doaj +1 more source
Nivolumab-Induced de novo Discoid Lupus Erythematosus
An increasing number of checkpoint inhibitor-induced subacute cutaneous lupus erythematosus events have been reported. We present the first case of nivolumab-induced discoid lupus erythematosus in a patient with hepatocellular carcinoma.
Jaya Manjunath, Mark Mochel, Fnu Nutan
doaj +1 more source
Subacute cutaneous lupus erythematosus starting as linear lupus erythematosus [PDF]
AbstractBackgroundCutaneous lupus in childhood is usually associated with systemic lupus erythematosus (LE). Linear cutaneous LE (LCLE) is an unusual presentation mostly seen in children and young adults.MethodsWe report a rare case of cutaneous subacute LE with a segmentary pattern following the lines of Blaschko in an 18‐month‐old girl with a 2‐month
Frances L +4 more
openaire +3 more sources
Subacute cutaneous lupus-erythematosus in childhood
Subacute cutaneous lupus erythematosus (SCLE) has been described in adults in the last decade and represents a particular homogenous subgroup in which the skin lesions can be distinguished from scarring discoid lupus lesions both on a morphologic and histopathologic basis. This entity, however, seems to be very uncommon in childhood.
Siamopoulou-Mavridou, A. +2 more
openaire +3 more sources
A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment
Cutaneous lupus erythematosus is a previously undiagnosed side-effect of ranibizumab. Here, we present a case of an 82-year-old female Caucasian patient with wet age-related macular degeneration.
Marko Andric +4 more
doaj +1 more source

